Ivermectin and the Crisis of Acceptance

This chapter examines the contentious debate surrounding the use of ivermectin during health crises, challenging rigid adherence to conventional evidence-based medicine. It critiques the perceived biases in scientific literature, particularly regarding publication bias, and emphasizes the need for transparency and openness in medical discussions. The speakers raise concerns about censorship and the influence of the pharmaceutical industry on public health discourse, questioning the decision-making processes surrounding treatment options.